We also tested the effectiveness of several immune checkpoint inhibitors and cytokines for the treatment of CRPC and found that IFNα treatment inhibited tumor growth and reduced the accumulation of G-MDSCs in the TME. This evidence concerns the gene IFNA1 and neoplasm.